Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$655M |
| 2 |
Coty
COTY
|
+$380M |
| 3 |
ConocoPhillips
COP
|
+$250M |
| 4 |
Zimmer Biomet
ZBH
|
+$213M |
| 5 |
Valero Energy
VLO
|
+$170M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$523M |
| 2 |
Merck
MRK
|
+$375M |
| 3 |
SHPG
Shire pic
SHPG
|
+$362M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$310M |
| 5 |
CELG
Celgene Corp
CELG
|
+$286M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 13.57% |
| 2 | Technology | 12.05% |
| 3 | Financials | 10.74% |
| 4 | Consumer Discretionary | 9.44% |
| 5 | Energy | 8.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2476
iShares Biotechnology ETF
IBB
$10.8B
| $1.75M | ﹤0.01% |
15,688
-470,972
| -97% | -$51.7M |
|
2477
Mercer International
MERC
$27.7M
| $1.75M | ﹤0.01% |
129,820
-1,035,215
| -89% | -$14.2M |
|
2478
GSI Technology
GSIT
$224M
| $1.75M | ﹤0.01% |
225,568
+70,818
| +46% | +$543K |
|
2479
CALL
Haemonetics
HAE
$4.85B
| $1.75M | ﹤0.01% |
+20,000
| New | +$1.82M |
|
2480
Kraft Heinz
KHC
$29.4B
| $1.75M | ﹤0.01% |
53,605
-272,452
| -84% | -$11.1M |
|
2481
ING
ING
$102B
| $1.75M | ﹤0.01% |
143,870
+92,016
| +177% | +$1.11M |
|
|
BHR
2482
Braemar Hotels & Resorts
BHR
$141M
| $1.74M | ﹤0.01% |
143,977
+96,830
| +205% | +$1.09M |
|
2483
iShares Russell 3000 ETF
IWV
$20.2B
| $1.74M | ﹤0.01% |
10,417
-18
| -0.2% | -$2.89K |
|
2484
Futu Holdings
FUTU
$17.9B
| $1.73M | ﹤0.01% |
+93,633
| New | +$1.62M |
|
2485
iShares MSCI Canada ETF
EWC
$6.91B
| $1.73M | ﹤0.01% |
62,600
-3,245
| -5% | -$87.5K |
|
|
ORC
2486
Orchid Island Capital
ORC
$1.33B
| $1.73M | ﹤0.01% |
52,452
-8,314
| -14% | -$284K |
|
|
PINC
2487
CALL
DELISTED
Premier
PINC
| $1.73M | ﹤0.01% |
50,000
+30,000
| +150% | +$1.11M |
|
|
GRA
2488
CALL
DELISTED
W.R. Grace & Co.
GRA
| $1.73M | ﹤0.01% |
+22,100
| New | +$1.63M |
|
2489
Bank7 Corp
BSVN
$493M
| $1.72M | ﹤0.01% |
99,209
-35,091
| -26% | -$552K |
|
2490
Digi International
DGII
$2.89B
| $1.72M | ﹤0.01% |
135,964
+87,622
| +181% | +$1.09M |
|
2491
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.84B
| $1.72M | ﹤0.01% |
51,433
+43,248
| +528% | +$1.47M |
|
2492
Vanguard FTSE Developed Markets ETF
VEA
$239B
| $1.72M | ﹤0.01% |
+41,995
| New | +$1.68M |
|
2493
Forward Air
FWRD
$596M
| $1.7M | ﹤0.01% |
26,282
+13,140
| +100% | +$804K |
|
2494
Gerdau
GGB
$8.75B
| $1.7M | ﹤0.01% |
552,490
-297,456
| -35% | -$964K |
|
|
EQC
2495
DELISTED
Equity Commonwealth
EQC
| $1.69M | ﹤0.01% |
51,704
-65,305
| -56% | -$2.09M |
|
2496
EyePoint Inc
EYPT
$430M
| $1.68M | ﹤0.01% |
+93,967
| New | +$2.23M |
|
|
GOGL
2497
DELISTED
Golden Ocean Group
GOGL
| $1.68M | ﹤0.01% |
352,165
+55,220
| +19% | +$302K |
|
|
TELL
2498
CALL
DELISTED
Tellurian Inc.
TELL
| $1.68M | ﹤0.01% |
150,000
-175,000
| -54% | -$1.64M |
|
|
GRMN
2499
Garmin
GRMN
$55.7B
| $1.68M | ﹤0.01% |
19,423
-37,794
| -66% | -$2.85M |
|
|
PBPB
2500
DELISTED
Potbelly
PBPB
| $1.68M | ﹤0.01% |
197,027
-432,518
| -69% | -$3.66M |
|
Similar funds
Israel Englander's Q1 2019 Portfolio in Review
As of Q1 2019, Israel Englander held 4,608 positions worth $66.8B, up 4.2% from $64.1B the previous quarter. Its ten largest holdings account for 7.1% of the portfolio.
Israel Englander withdrew a net $6.14B in Q1 2019, closing 675 positions and reducing 1,467 holdings. Its most notable exit was Merck, an estimated $375M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Technology and Financials.
Against the trend, Israel Englander opened a new position in Zimmer Biomet worth $232M.
- Israel Englander's largest Q1 2019 buy was Zimmer Biomet: 1,870,503 shares worth $232M.
- Israel Englander added most to Walt Disney in Q1 2019, an estimated $655M increase.
- Israel Englander's biggest Q1 2019 reduction was Apple, cutting an estimated $523M.
- Israel Englander fully exited Merck in Q1 2019, selling an estimated $375M.
- Israel Englander's ten largest holdings make up 7.1% of its $66.8B portfolio in Q1 2019.
- Israel Englander opened 914 new positions and closed 675 in Q1 2019.
- Israel Englander's portfolio value rose 4.2% quarter-over-quarter to $66.8B.
Based on Millennium Management's 13F filing for Q1 2019, filed 14 May 2019.